Prescription coverage for dual-eligible dementia patients runs mainly through an automatically assigned Medicare drug plan with Extra Help lowering costs and yearly spending capped. Dual-eligible means having both Medicare and full-benefit Medicaid, with Medicare paying first for Medicare-covered services and Medicaid paying last. For routine prescriptions, Medicaid does not replace the Part D plan. Families work through Medicare formularies, pharmacy networks and approval rules first, then check Medicaid for leftover costs and drugs Part D does not cover.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who pays first for prescriptions?
- How does Extra Help lower drug costs?
- Are newer Alzheimer's antibody drugs covered?
- Where can access still break down?
- What should families confirm next?
Who pays first for prescriptions?
Medicare.gov explains that people with both Medicare and full-benefit Medicaid are dually eligible and that Medicare pays first while Medicaid pays last, as described in Medicare's Medicaid guidance. Prescription drugs come through the assigned Medicare drug plan rather than through Medicaid.
That order matters for dementia care. Daily drugs for memory symptoms, mood, sleep and other conditions go through Part D rules. Medicaid can then help with certain remaining premiums, deductibles and drugs outside Part D.
How does Extra Help lower drug costs?
Medicare.gov states that full-benefit Medicaid recipients automatically receive Extra Help, which pays Part D premiums, deductibles, coinsurance and other drug costs with no late-enrollment penalty while enrolled, as described in Medicare's help with drug costs. Medicare re-evaluates Extra Help yearly, so patients keep it through December 31 even if income changes midyear and stay in the same plan unless Medicare or Social Security sends a change notice.
For all Part D enrollees including duals, CMS set annual out-of-pocket spending on covered drugs at $2,100 in 2026, after which covered drugs cost $0 for the rest of the year, according to the CMS final 2026 Part D instructions. The cap applies only to covered Part D drugs. Families should still check whether a specific drug is covered and what pharmacy rules apply.
Are newer Alzheimer's antibody drugs covered?
The Food and Drug Administration converted Leqembi to traditional approval after a confirmatory trial verified clinical benefit for adult Alzheimer's disease. That makes it a standard FDA-approved option for eligible patients, not an experimental approval.
CMS covers FDA-approved amyloid-directed antibodies only under coverage with evidence development for mild cognitive impairment or mild dementia with confirmed amyloid pathology, as set out in the CMS national coverage decision. Both clinician and patient must take part in a CMS-approved registry or study. Families should confirm amyloid testing and registry enrollment before seeking Leqembi or Kisunla under Part B.
Where can access still break down?
A Journal of Alzheimer's Disease modeling study reported in PubMed Central found that state Medicaid lesser-of rules may pay less than full Medicare cost-sharing for duals. Researchers link lower payment to clinician reluctance to accept Medicaid.
The study modeled disparities in Alzheimer's diagnostic evaluation despite higher disease burden. For caregivers, the warning is practical. Coverage on paper does not always mean a nearby clinic will order testing, give infusions or join the required registry.
What should families confirm next?
Use a Part D plan or integrated Dual Eligible Special Needs Plan for prescriptions. Confirm testing, eligibility and registry steps before pursuing antibody treatment under Part B.
Ask Medicaid what remains for premiums, deductibles and non-Part D drugs. Keep approval letters, test results and plan notices together for each refill, appointment and coverage question.
- Confirm the current Part D plan, formulary and pharmacy.
- Confirm Extra Help status and any change notice.
- For antibody treatment, confirm amyloid pathology, stage, registry and Part B rules.
- Ask Medicaid about leftover cost-sharing and excluded drugs.
